Literature DB >> 4459276

Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.

L Milas, J U Gutterman, I Basic, N Hunter, G M Mavligit, E M Hersh, H R Withers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4459276     DOI: 10.1002/ijc.2910140409

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  6 in total

1.  Adjuvant treatment of colorectal cancer.

Authors:  J S Nystrom; J R Bateman; J Weiner
Journal:  West J Med       Date:  1977-02

2.  Enhancement of tissue invasion in murine aspergillosis by systemic administration of suspensions of killed Corynebacterium parvum.

Authors:  D M Purnell
Journal:  Am J Pathol       Date:  1976-06       Impact factor: 4.307

3.  Antitumor activity of Listeria monocytogenes on a guinea pig fibrosarcoma.

Authors:  M M Dustoor; A Fulton; W Croft; A A Blazkovec
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

4.  Adjuvant immune stimulation with Corynebacterium parvum during maintenance chemotherapy of acute myeloid leukemia. A prospective randomized study.

Authors:  E la Cour Petersen; P Hokland; J Ellegaard
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

5.  Complement activation in vivo in cancer patients receiving C. parvum immunotherapy.

Authors:  H Biran; J L Moake; R C Reed; J U Gutterman; E M Hersh; E J Freireich; G M Mavligit
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

6.  CpG plus radiotherapy: a review of preclinical works leading to clinical trial.

Authors:  Kathy A Mason; Nancy R Hunter
Journal:  Front Oncol       Date:  2012-08-14       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.